I am a leading author and contributor on several financial websites, namely TalkMarkets, Seeking Alpha and INO.com. I cover a broad range of investment strategies; currency hedging, value, growth, options and dividend investing. I also cover long-term wealth creating strategies such as leveraging ...more

I am a leading author and contributor on several financial websites, namely TalkMarkets, Seeking Alpha and INO.com. I cover a broad range of investment strategies; currency hedging, value, growth, options and dividend investing. I also cover long-term wealth creating strategies such as leveraging 401ks, Roth IRAs and Health Savings Accounts (HSAs) to augment one's long-term investment approach. My area of emphasis is geared towards the overall healthcare industry (i.e. biotechnology, health insurers, large pharma, pharmacy benefit managers and pharmaceutical wholesalers) highlighting sector trends, political backdrop/current events, key developments and mergers and acquisitions. I authored a bi-monthly newsletter covering these topics in collaboration with INO.com.​ In partnership with INO.com, I author a bi-monthly newsletter service titled "Political Plays". In an effort to assist traders and investors to bridge the gap between Washington and Wall Street and provide actionable updates driven by political action. This is an apolitical newsletter assessing the potential impact of proposed and ongoing legislation across a broad range of industries occurring at the federal level. I am a biotechnology professional with a diverse scientific background and detailed knowledge in many therapeutic areas such as monoclonal antibodies and immunotherapies. I have a deep understanding of the clinical and regulatory aspects with respect to drug development and drug approvals. I have a personal interest in finance, investing and specifically options trading. My investment strategy is long-term/retirement oriented while exploring avenues to maximize wealth in retirement. My analyses are focused on individual stocks, sector trends and niche opportunities such as options trading. ​less